SAO PAULO (Reuters) – Brazilian biotech company Biomm SA has signed an exclusive deal to distribute Cansino Biologics’ COVID-19 vaccine in Brazil, a securities filing showed on Friday.
Biomm said the agreement includes a potential production of the vaccine in its plant in Minas Gerais. The company will send Brazilian healthcare authority Anvisa a new requirement for the emergency use of Cansino’s vaccine in Brazil.
(Reporting by Carolina Mandl; editing by Jason Neely)
